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Objective: Hyperpolarizing cardioplegia has recently been proposed for myo- 
cardial protection. To compare the protective ffect of hyperpolarizing cardio- 
plegia and depolarizing (hyperkalemic) eardioplegia on coronary endothelium, 
we studied porcine coronary arteries in the organ chamber. Methods: Relax- 
ation mediated by the endothelium-derived hyperpolarizing factor (EDHF) 
was used as the index of endothelial function because (1) hyperkalemia without 
ischemia does not impair the nitric oxide-mediated function according to 
previous tudies and (2) EDHF relaxes vessels by hyperpolarizing the mem- 
brane potential. Therefore depolarizing cardioplegia may inhibit this function, 
but hyperpolarizing cardioplegia may preserve it. EDHF-mediated relaxation 
was induced by bradykinin and the calcium ionophore A23187 with the 
presence of indomethacin (7 pmol/L; INN: indometacin), a cyclooxygenase 
inhibitor, and NG-nitro-L-arginine (300 pmol), a nitric oxide biosynthesis 
inhibitor in U46619 (30 nmol/L)-induced preeontraction. The vessels were 
exposed to either hyperpolarizing cardioplegic solution (the potassium-chan- 
nel opener aprikalim, 0.1 mmol/L) or depolarizing cardioplegic solution (high 
potassium concentration, 20mmol/L for A23187 and 50 mmol/L for bradykinin 
experiments) for 1 hour with a constant supply of oxygen to exclude the effect 
of ischemia. Results: EDHF-mediated relaxation was significantly impaired in 
either A23187 or bradykinin studies (80.1% -+ 7.5% vs 24.9% _.+ 14.2%, p = 
0.004, n = 8 in each group for A23187, and 71.4% + 4.7%, n = 13, vs 40.5% -+ 
12.9%, n = 7, p = 0.01, for bradykinin). The effective concentration causing 
50% of maximal relaxation was significantly increased in the A23187 experi- 
ments with the treatment of hyperkalemia. In contrast, in aprikalim-treated 
arteries, the EDHF-mediated relaxation induced by either A23187 or bradyki- 
nin was unchanged. Conclusions: We conclude that EDHF-mediated coronary 
endothelial function is maximally preserved by hyperpolarizing cardioplegia 
but impaired by depolarizing cardioplegia, These findings support the use of 
hyperpolarizing cardioplegia in cardiac operations. (J Thorac Cardiovasc Surg 
1997;114:643-50) 
epolarizing cardioplegia is the most common 
method for myocardial preservation in cardiac 
operations. 1 Potassium at high concentrations (hy- 
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perkalemia, usually a potassium concentration of 10 
to 20 mmol/L) is the major depolarizing agent in 
cardioplegic solutions. Despite the cardioprotective 
effect, depolarizing cardioplegia causes depolarization 
of the membrane potential by extracellular hyperkale- 
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mia, resulting in depletion of energy stores and cal- 
cium overload. 2 Depolarization of the membrane is 
associated with an ongoing cellular metabolic process 
and derangements in transmembrane ionic gradierits. 2 
It is also associated with influx of sodium through the 
sodium "window current," exchange of intracellular 
sodium for calcium via the Sodium-calcium exchange, 
influx of calcium through the calcium "window cur- 
rent, ''3 and leakage of calcium from the sarcoplasmic 
reticulum. These factors contribute to myocardial cal- 
cium overload, which is related to myocardial injury 
during the arrest. 
As a result of these considerations, hyperpolariz- 
ing cardioplegia has been proposed to induce car- 
diac arrest during cardiac operations. 2' 4 The natural 
resting state of the cardiac myocyte is at hyperpo- 
larized membrane potentials. 2 Few channels or 
pumps are activated at hyperpolarized potentials, 
and metabolic demand on the ventricular myocyte is
minimal at this status. 
Potassium-channel openers have been suggested 
as a means of cardiac protection, z' 4, 5 Adenosine 
triphosphate (ATP)-sensitive potassium-channel 
openers inhibit the development of myocardial con- 
tracture, reduce the release of lactate dehydroge- 
nase, and preserve intracellular ATP content during 
ischemia.6, 7 Therefore use of potassium-channel 
openers for cardioplegia is a potential method for 
cardiac protection during cardiac operations. Be- 
cause of the hyperpolarizing effect of potassium- 
channel openers on the membrane potential of 
myocytes, cardioplegia using potassium-channel 
openers has been defined as "hyperpolarizing car- 
dioplegia. ''~ Studies have demonstrated that hyper- 
polarizing cardioplegia significantly prolongs the 
period to the development of myocardial contrac- 
ture z 4, 5 and affords a significantly better postisch- 
emic recovery of function than hyperkalemic depo- 
larizing arrest. 2
The effect of potassium-channel openers on the 
heart includes two aspects: their effect on myocytes 
and their effect on the coronary circulation. Theo- 
retically, in addition to the cardioprotective effect on 
the myocytes, the vasorelaxant action of potassium- 
channel openers may provide another important 
benefit o myocardial protection. Potassium-channel 
openers are belieVed to relax blood vessels through 
hyperpolarization f the membrane potential of the 
smooth muscle. This subsequently affects voltage- 
operated calcium channels and intraceilular calcium 
release and therefore relaxes the vesset, s'9 The 
coronary vasodilatation bviously facilitates myocar- 
dial perfusion during the reperfusion period. 
During arrest of the heart, the cardioplegic solu- 
tion directly contacts the coronary vascular endothe- 
lium. Therefore an important question is whether 
exposure to cardioplegic solution alters endothelial 
function. Although the effect of cardioplegia on 
coronary endothelial function has been studied, to 
date the effect of hyperpolarizing cardioplegia has 
not been reported. 
Endothelium-dependent relaxation is known to 
be due to a variety of different endothelium-derived 
relaxing factors (EDRFs). These are endothelium- 
derived nitric oxide (EDNO), epoprostenol (prosta- 
cyclin [PGI2]), and endothelium-derived hyperpo- 
larizing factor (EDHF). The nature of EDHF has 
not been conclusively identified, although most re- 
cently the cytochrome P450-monooxygenase metab- 
olite of arachidonic acid has been suggested to be 
EDHF.W, 11 EDHF induces vascular smooth muscle 
relaxation by hyperpolarization f the smooth mus- 
cle cells, 12-19 which may involve potassium chan- 
nels.~5. 17. 19.20 In contrast, EDNO mainly relaxes 
blood vessels through the cyclic guanosine mono- 
phosphate pathway. All of these EDRFs are re- 
leased in response to the increase of intracellular 
(cytosolic free) calcium concentration i the endo- 
thelial cell. 19 
Our previous tudies 19' 21 have demonstrated that 
when EDNO and PGI 2 pathways are inhibited, 
endothelium-dependent relaxation is still signifi- 
cant. obviously as a result of the effect of the third 
component, EDHF. The studies also demonstrated 
that in porcine coronary arteries precontracted with 
the depolarizing agent potassium 21or U46619.19 this 
residual relaxation mediated by EDHF is signifi- 
cantly reduced by exposure to hyperkalemia (a 
potassium concentration of 20 to 50 mmol/L). We 
have recently demonstrated that exposure to hyper- 
kalemia alters the EDHF-related coronary vasore- 
laxant effect by prolonging the depolarization, af- 
fecting the calcium-activated 19 potassium channels, 
and to a lesser extent affecting the ATP-sensitive 
potassium channels. Theoretically, hyperpolarizing 
arrest may preserve the EDHF-related vasorelaxant 
function because both potassium-channel openers 
and EDHF relax blood vessels through hyperpolar- 
ization of the smooth muscle membrane potential. 
The present study was designed to compare the 
effect of hyperpolarizing cardioplegia nd the effect 
of depolarizing cardioplegia on EDHF-related cor- 
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onary endothelium-smooth muscle interaction in 
porcine coronary arteries. The potassium-channel 
opener aprikalim was used as the hyperpolarizing 
agent. A non-receptor-mediated (A23187) and a 
receptor-mediated (bradykinin) EDHF agonist was 
used in the present study. 
Materials and methods 
Coronary arteries were obtained from porcine hearts 
that were harvested in a local abattoir. Immediately after 
the hog (either sex) was killed, the heart was rapidly 
removed, placed in a container filled with Krebs solution 
at 4 ° C, and transferred to the laboratory. Epicardial 
coronary arteries were dissected free from the surround- 
ing connective tissue, cut into 3 mm long rings, and 
mounted on a pair of stainless steel wires in organ 
chambers23.24 filled by Krebs solution at 37 ° C. The Krebs 
solution had the following composition (in millimoles per 
liter): Na + 144, K + 5.9, Ca 2+ 2.5, Mg 2÷ 1.2, C1- 128.7, 
I~CO 3- 25, SO42 1.2, H2PO 4 1.2, and glucose 11. The 
solution was aerated with a gas mixture of 95% oxygen 
and 5% carbon dioxide at 37 ° C. Six organ chamber 
arrangements were run concurrently. 
A previously described organ chamber technique = 
was used to normalize vascular ings under a pressure 
simulating the conditions encountered in the artery at 
its normal transmural pressure, according to their own 
length-tension curves. The normalization procedure 
was performed with a computerized program 
(VESTAND 2.1 by Yang-Hui He, Princeton University, 
Princeton, N.J.). 
The endothelium was intentionally preserved by cau- 
tiously dissecting and mounting the rings. 19' 23-25 To ex- 
amine the endothelium dependence on the relaxation to 
A23187 or bradykinin (n = 4 in each group), in some rings 
we removed the endothelium echanically by using a fine 
wood stick moistened with Krebs solution to gently rub 
the intima of the rings. This method is able to eliminate 
the endothelium-dependent r laxation in the porcine cor- 
onary artery. 19' 21 In endothelium-denuded rings, nitro- 
glycerin (-4.5 log M) was added at the end of the 
experiments o test whether those rings were still able to 
be relaxed with this endothelium-independent vasorelax- 
ant agent. 23' 24 
Protocol. All rings were equilibrated for 30 minutes 
before and after normalization. 
The effect of aprikalim or potassium on the coronary 
tone. At resting status, a group of coronary rings were 
incubated with either aprikalim (-4 log M) added in the 
Krebs solution or the depolarizing agent potassium (20 
retool/L, replacing sodium) for 1 hour. The coronary 
artery tension was continuously recorded. 
The effect of aprikalim or potassium on the EDHF- 
mediated relaxation. Coronary artery rings were exposed 
to aprikalim (-4 log M) for 1 hour. The rings were then 
repeatedly washed for 30 minutes. Indomethacin (7 
~zmol/L; INN: indometacin), a cyclooxygenase inhibitor, 
and A~-nitro-L-arginine (L-NNA, 300 ptmol/L), a nitric 
oxide biosynthesis/release inhibitor, were added for 30 
minutes. U46619 (30 nmol/L) was then added to contract 
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Fig. 1. Coronary vascular tone during exposure to depo- 
larization (potassium 20 mmol/L, K20) and hyperpolariza- 
tion (aprikalim 100 /,mol/L, APK-4). The depolarizing 
cardioplegic solution significantly contracted the coronary 
artery, but the hyperpolarizing solution relaxed the artery. 
n = 8 in each group. 
the artery. When the contraction reached the plateau, the 
concentration-relaxation curve to A23187 or bradykinin 
( -10 to -6.5 log M) was established. The group data were 
compared with data from the control rings (without 
aprikalim treatment). 
A similar protocol was used for the depolarizing car- 
dioplegia (20 mmol/L concentration of potassium in 
Krebs solution, replacing sodium in A23187 experiments, 
and 50 mmol/L concentration of potassium in bradykinin 
experiments). 
Indomethacin and L-NNA were added 30 minutes 
before the concentration-relaxation curves for A23187 
and bradykinin were started. From a number of rings in 
each group of experiments, a mean concentration-relax- 
ation curve was constructed. During the experiments, the 
solutions in the organ chamber were continuously aerated 
with a mixture of 95% oxygen and 5% carbon dioxide to 
exclude the effect of ischemia. 
Data analysis. The effective concentration f the relax- 
ation agent that caused 50% of maximal contraction (or 
relaxation) was defined as ECso. The estimated ECso was 
determined from each concentration-relaxation curve by a 
logistic, curve-fitting equation: 
E = MAP/(A P + K e) 
where E is response, M is maximal contraction (or relax- 
ation), A is concentration, K is EC5o concentration, and P 
is the slope parameter. 2~' 22 From this fitted equation, the 
mean ECso value _+ standard error of the mean was 
calculated for each group. 
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Fig. 2. Mean concentration (-log M)-relaxation (percentage of contraction by U46619 30 nmol/L) curves 
for EDHF-mediated relaxation induced by A23187 in the coronary arteries exposed to depolarization 
(potassium 20 mmol/L [K20], A) or hyperpolarization (aprikalim 100/~mol/L [APK-4], B) for 1 hour. The 
experiments were performed inthe presence of indomethacin (7/xmol/L), acyclooxygenase inhibitor, and 
L-NNA (300/xmol/L), anitric oxide biosynthesis/release inhibitor, n = 8 in each group. E-, Endothelium- 
denuded arteries (n = 4). **p < 0.01. 
Table I. Precontraction force (grams') induced by U46619 
Control Depolarizing* p Value Control Hyperpolarizing/ p Value 
A23187 12.9 - 0.8 i3.8 -+ 2.5 0.7 12.9 _+ 0.8 14.3 -+ 0.8 0.2 
Bradykinin 9.8 -+ 1.1 10.3 -+ 4.7 0.7 10.0 + 0.8 10.1 -+ t.3 0.9 
The experiments were conducted at the presence of indomethacin (7 ~mol/L) and N°-nitro-L-arginine (300/~mol/L). 
*Incubation with potassium (20 mmol/L in A23187 and 50 mmol/L in bradykinin experiments) for 1 hour. 
?Incubation with aprikalim (100 p~mol/L) for 1 hour. 
Statistical analysis. Data were analyzed by analysis of 
variance (followed by Scheffe's test) or by the unpaired t 
test; p < 0.05 was considered significant. 
Drugs. Drugs used and their sources were as follows: 
A23187, bradykinin, L-NNA, and indomethacin (Sigma 
Chemical Co., St. Louis, Mo.) and U46619 (Cayman 
Chemical Co., Ann Arbor, Mich.). L-NNA (dissolved in 
distilled water) and indomethacin (dissolved in ethanol) 
were stored at 4 ° C. The solution of U46619 was held 
frozen until required. 
Results 
Basal tone during incubation with potassium or 
aprikalim. A significant difference with regard to 
vascular tone during incubation was noted between 
the potassium and aprikalim groups. In aprikalim- 
incubated rings, the tone significantly decreased 
(-6.3 -+ 1.3 gin). In contrast, the tone significantly 
increased in the rings incubated with potassium 
(11.6 + 2.5 gm, p < 0.001) (Fig. 1). 
Comparison of precontraction. Precontraction 
by U46619 was comparable in the experiments. 
Table I gives details of the precontraction force. 
EDHF-mediated relaxation 
Depolarizing agent (potassium) exposure 
A23187-INDUCED RELAXATION. A23187-induced 
relaxation was 80.1% _+ 7.5% (n = 8) in the control 
rings and was reduced to 24.9% + 14.2% in the 
potassium-incubated rings (n = 8,p = 0.004) (Fig. 2, 
A). The ECs0 was -7.21 _+ 0.02 log M in the control 
rings. We were unable to calculate it in the rings 
after treatment with hyperkalemia because in some 
rings the relaxation was eliminated (Table II). This 
implies a significant difference compared with the 
control rings. 
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Fig. 3. Mean concentration (-log M)-relaxation (percentage of contraction by U46619 30 nmol/L) curves 
for EDHF-mediated relaxation induced by bradykinin in the coronary arteries exposed to depolarization 
(potassium 50 mmol/L [K50], n = 7 vs n = 13 in the control group; A) or hyperpolarization (aprikalim 100 
tzmol/L, APK -4, n = 7 vs n = 7 in the control group; B) for 1 hour. The experiments were performed in
the presence of indomethacin (7/xmol/L) and L-NNA, 300/xmol/L. E-, Endothelium-denuded arteries (n = 
4). *p < 0.05. 
Table II. ECso values (-log 3/1) for the EDHF-mediated relaxations in the porcine coronary artery 
Control Depolarizing* p Value Control Hyperpolarizing? p Value 
A23187 7.21 -+ 0.02 $ 7.21 _+ 0.02 7.24 _+ 0.13 0.7 
Bradykinin 8.19 -+ 0.18 7.38 ± 0.43 0.06 7.77 _+ 0.11 8.20 _+ 0.07 0.03 
I 
-6 
The experiments were conducted at the presence of indomethacin (7txmol/L) and N~-nitro-L-arginine (300 bcmol/L). 
*Incubation with potassium (20/xmol/L in A23187 and 50 mmol/L in bradykinin experiments) for 1 hour. 
tlncubation with aprikalim (100/xmol/L) %r 1 hour. 
Sin some preparations the relaxation was almost otally abolished so that the ECso was not able to be calculated. This implies a significant difference compared 
with the control group. 
BRADYKININ-INDUCED RELAXATION. Bradykinin-in- 
duced relaxation was 71.4% _+ 4.7% (n = 13) in the 
control rings and was reduced to 40.5% _+ 12.9% in 
the potassium-incubated rings (n = 7, p = 0.01) 
(Fig. 3, A). The ECso was 6.5-fold higher after 
treatment with hyperkalemia, although the differ- 
ence did not reach statistical significance (p = 0.06) 
(Table II). 
Hyperpolarizing agent (aprikalim ) exposure 
A23187-INDUCED RELAXATION. A23187-induced 
relaxation was 80.1% + 7.5% (n = 8) in the control 
rings and 74.6% _+ 6.9% in the aprikalim-incubated 
rings (n = 8, p = 0.6) (Fig. 2, B). 
BRADYKININ-INDUCED RELAXATION. Bradykinin-in- 
duced relaxation was 69.8% -- 10.5% (n = 7) in the 
control rings and 68.3% _+ 5.9% in the aprikalim- 
incubated rings (n = 7, p = 0.9) (Fig. 3, B). 
In A23187-induced relaxation, the ECs0 was sim- 
ilar in the control and the aprikalim-treated arteries 
(-7.21 + 0.02 vs -7.24 _+ 0.13 log M, p = 0.7). In 
bradykinin experiments, the relaxation was slightly 
potentiated in the arteries treated with aprikalim 
(-8.20 _+ 0.07 vs -7.77 ± 0.11 log M in the control 
rings, p = 0.03) (Table II). 
In endothelium-denuded rings, neither A23187 
nor bradykinin induced any relaxation, a fact which 
confirms that the relaxations observed in the present 
study were endothelium-dependent (Figs. 2 and 3). 
Discussion 
The present study has demonstrated for the first 
time that hyperpolarizing arrest may be superior to 
depolarizing arrest with regard to the preservation 
of EDHF-related endothelium-smooth muscle in- 
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Fig. 4. Schematic diagram describing the possible pathway by which depolarizing (hyperkalemia) nd 
hyperpolarizing (aprikalim) may affect the interaction between endothelium and smooth muscle. In 
response to the increase of the intracellular (cytosolic free) calcium level, endothelial cells derive three 
major EDRFs (PGI2, EDNO, and EDHF). These EDRFs decrease the intracellular calcium concentration 
in the smooth muscle cell through different mechanisms and ultimately relax the smooth muscle cell. The 
mechanism of EDHF to relax vessels is to open potassium channels and hyperpolarize the membrane. 
Subsequently, the voltage-operated calcium (Ca 2÷) channels are inhibited and therefore the calcium influx 
is reduced, and this causes relaxation. Use of hyperpolarizing cardioplegia may enhance this function 
because both potassium-channel openers (KCO) and EDHF relax the vessel by hyperpolarizing the 
membrane. In contrast, exposure to depolarizing cardioplegia (hyperkalemia) reduces the EDHF- 
mediated relaxation by affecting potassium channels and prolonged epolarization. 
teraction and, therefore, may provide better protec- 
tion to the coronary circulation and the heart. 
The role of EDHF in the coronary circulation. 
EDHF has been suggested to play a role in coronary 
arteries.t9, 20, 26, 27 In the present study we found 
that when the other two components of EDRFs- -  
EDNO and PGI2--were inhibited, both A23187 and 
bradykinin induced more than 70% relaxation, and 
this residual relaxation is still endothelium-depen- 
dent. This observation is consistent with findings 
from our previous studies, 19' 21 which demonstrate 
that EDHF is one of the active EDRFs in the 
coronary circulation. Most recently, we have shown 
that this activity is also present in the human coro- 
nary circulation. 2s Therefore "perfect" cardiac pro- 
tection should include the preservation of this com- 
ponent of endothelial function. 
Effect of hyperpolarizing cardioplegia on vascular 
tone. Use of hyperpolarizing instead of depolar- 
izing cardioplegia is a recent suggestion for myo- 
cardial protection. 2'4 However, such studies are 
still in the animal experimentation stage. It has 
been suggested that hyperpolarizing cardioplegia 
may have advantages over depolarizing cardiople- 
gia in terms of protecting the myocardium. 2' 4 
However, the effect of hyperpolarizing cardiople- 
gia on the coronary circulation has not been 
studied. Theoretically, in contrast o depolarizing 
cardioplegia, which may contract the coronary 
arteries because of the high potassium concentra- 
tion, hyperpolarizing cardioplegia using vasodita- 
tors (potassium-channel openers) has a vasorelax- 
ant effect. This effect is well demonstrated in the 
present study. When the coronary arteries were 
incubated with aprikalim, the basal tone de- 
creased to -6.3 gm, and this showed an excellent 
vasorelaxant effect of this potassium-channel 
opener in the coronary circulation as demonstrated 
in other vessels. 29 In contrast, when the arteries 
were incubated with a 20 mmol/L concentration of
potassium, the tone increased to 11.6 gm owing to 
the vasoconstrictor effect of potassium. 
EDHF-related relaxation and depolarizing/hyper- 
polarizing cardioplegia. In our studies, other two 
major components of endothelium-dependent r lax- 
ation--the cyclooxygenase and EDNO pathways-- 
were blocked by indomethacin and L-NNA. There- 
fore the residual relaxation is obviously through the 
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non-cyclooxygenase and non-EDNO mechanism, 
that is, related to the effect of EDHF. 
As shown in our studies, EDHF-mediated relax- 
ation was reduced to 24.9% in A23187-induced 
relaxation and to 40.5% in bradykinin-induced re- 
laxation. Taken together with the results from the 
previous tudy, 21 our data suggest that the reduction 
of the residual relaxation by hyperkalemia is not 
agonist-dependent. Therefore this effect is a uni- 
form phenomenon affecting the coronary endothe- 
lium--smooth muscle interaction. 
In the current study, we used a 20 mmol/L con- 
centration of potassium as the depolarizing agent 
because this is a concentration used in cardioplegic 
solutions by various institutions (such as St. Vincent 
Hospital, Portland). In addition, although the theo- 
retic concentration of potassium in St. Thomas' 
Hospital cardioplegic solution is 16 retool/L, in 
clinical practice it varies between 16 and 21 mmol/L, 
as we measured aily when this solution was pre- 
pared during surgery in the operating room. With 
regard to higher concentrations of potassium, owing 
to the fact that the potassium concentration is as 
high as 125 mmol/L in organ preservation solutions 
such as University of Wisconsin solution, we arbi- 
trarily chose a moderately high concentration (50 
mmol/L) to test whether the effect at 20 mmol/L still 
exists at higher concentrations. 
As mentioned earlier, EDHF relaxes blood vessels 
by hyperpolarizing the smooth muscle membrane, 
similar to potassium-channel openers. Therefore both 
potassium-channel openers and EDHF relax smooth 
muscle by hyperpolarizing the cellular membrane of 
the smooth muscle, and the use of potassium-channel 
openers hould not influence the effect of EDHF. This 
hypothesis i supported by the present study. In our 
experiments, the use of aprikalim did not affect subse- 
quent EDHF-mediated relaxation induced by either 
A23187 or bradykinin. 
In our experiments, EDHF-mediated function 
was not tested during exposure to cardioplegic so- 
lution. In fact, it was measured after the repeated 
wash of the cardioplegic solution for at least half an 
hour, as in the previous studies. 19'21 This period 
simulates the "reperfusion" period. The results from 
the present study suggest that the inhibitory effect of 
the depolarizing but not the hyperpolarizing car- 
dioplegic solution on EDHF-mediated relaxation 
lasts for at least half an hour after washout and 
therefore still exists during the "reperfusion" period. 
In summary, our experiments suggest that one of 
the coronary endothelial functions, EDHF-medi- 
ated relaxation, is impaired by depolarizing cardio- 
plegia but preserved by hyperpolarizing cardiople- 
gia. Fig. 4 illustrates the mechanism of this effect. 
Depolarizing cardioplegia reduces EDHF-mediated 
relaxation by depolarizing the membrane and pos- 
sibly also by affecting potassium channels. In con- 
trast, hyperpolarizing cardioplegia with potassium- 
channel openers hyperpolarizes the membrane 
potential and therefore is synergistic to the effect of 
EDHF. 
Clinical implications. As suggested before, both 
EDNO and EDHF are active in regulating the tone 
of the coronary circulation. Therefore impairment 
of EDHF-mediated endothelial function could be 
harmful to cardiac function after cardiac arrest by 
cardioplegia. When EDNO function is impaired by 
ischemia,30.31 the EDHF function, as the reserve for 
endothelium-dependent relaxation, is more impor- 
tant in regulating coronary tone. The present study 
suggests that hyperpolarizing cardioplegia may be 
superior to depolarizing cardioplegia in view of the 
preservation of endothelial function related to 
EDHF, in addition to the preservation of cardiac 
myocytes, as demonstrated by others. 2
We conclude that depolarizing arrest (exposure to 
hyperkalemia) reduces EDHF-mediated relaxation, 
but hyperpolarizing arrest (with potassium-channel 
openers) preserves this function of the endothelium. 
In addition to the previous findings that hyperpolar- 
izing cardioplegia may effectively protect he cardiac 
myocytes, our study supports the use of hyperpolar- 
izing cardioplegia in cardiac operations from the 
view of preserving coronary endothelial function. 
Further studies are warranted to test this effect in in 
vivo models. 
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